What is Johnson Matthey?
Johnson Matthey is a UK speciality chemicals company that creates a wide range of hi-tech products. The business is divided into four main units: Clean Air, Efficient Natural Resources, Health and New Markets. It develops everything from emission control catalysts and advanced glass technologies to synthetic stimulants and fuel cell components. Its products are used across dozens of different industries, including food, jewellery, pharmaceuticals and the oil and gas industry.
Johnson Matthey says its ambition is to be “one of the best performing, most trusted and admired speciality chemicals companies in the world”. The company prides itself on being a leader in sustainable technologies. According to Johnson Matthey, over 93% of its sales now come from products and services which provide sustainability benefits through the positive impact they have on the environment, resource efficiency and human health.
As of 5 February 2018, Johnson Matthey was ranked 71st in the FTSE 100 index, with a market capitalisation of £6.4 billion. For the latest Johnson Matthey share price, check out Capital.com.
Who are the key people at Johnson Matthey?
Robert MacLeod has been Chief Executive of Johnson Matthey since June 2014, having previously held the role of Group Finance Director for 5 years. Among other key figures at the company are Anna Manz, Chief Financial Officer; and John Walker, who is Sector Chief Executive, Clean Air. Tim Stevenson has served as Chairman of Johnson Matthey since July 2011.
What is the modern history of Johnson Matthey?
Johnson Matthey can trace its history back to 1817, when Percival Johnson founded his gold assaying business in London with just £150 of capital. The firm grew rapidly, becoming official assayers to the Bank of England, and in the mid-20th century it expanded into Asia and North America, supplying electrocatalysts to the NASA space program for example. In the latter decades of the 20th century the company started producing emission control catalysts and platinum-based anti-cancer drugs; and since 2000 it has further extended its offering across both sectors and geographies.
What are the latest developments at Johnson Matthey?
In 2017 Johnson Matthey launched Sustainability 2017, a major corporate initiative setting out the company’s commitment to developing sustainable technologies and a sustainable business.
In its half year results for the six months to 30 September 2017, Johnson Matthey highlighted its strong operational momentum and confirmed its full year outlook. The company reported revenue up 15% in the half year, though operating profit was down 2%, with an £18 million translational FX benefit offset by one-off charges related to its restructuring programme.
CEO Robert MacLeod said the company aimed to grow its Clean Air business over the next 10 years, driven by the challenges of meeting tighter legislation around the world – especially in China and Europe. He said the company’s growing pipeline in Health would deliver significant growth over the medium term.
Our JMAT chart will show you the ups and downs of Johnson Matthey’s share price over recent weeks and months.
Where does Johnson Matthey operate?
Johnson Matthey has business operations in more than 30 countries and employs around 13,000 people worldwide. The company has 14 major manufacturing facilities in Europe, 12 in North America, 12 in Asia and 5 in the rest of the world. Its headquarters are in London.
Where is Johnson Matthey traded?
Johnson Matthey share prices are quoted on the London Stock Exchange (LSE). The company has been a member of the FTSE 100 index since 2002. Check out Capital.com for the latest JMAT chart.